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Selective effect of cell membrane 
on synaptic neurotransmission
Pekka A. Postila1,2, Ilpo Vattulainen1,3,4 & Tomasz Róg1
Atomistic molecular dynamics simulations were performed with 13 non-peptidic neurotransmitters 
(NTs) in three different membrane environments. The results provide compelling evidence that NTs are 
divided into membrane-binding and membrane-nonbinding molecules. NTs adhere to the postsynaptic 
membrane surface whenever the ligand-binding sites of their synaptic receptors are buried in the lipid 
bilayer. In contrast, NTs that have extracellular ligand-binding sites do not have a similar tendency 
to adhere to the membrane surface. This finding is a seemingly simple yet important addition to the 
paradigm of neurotransmission, essentially dividing it into membrane-independent and membrane-
dependent mechanisms. Moreover, the simulations also indicate that the lipid composition especially in 
terms of charged lipids can affect the membrane partitioning of NTs. The revised paradigm, highlighting 
the importance of cell membrane and specific lipids for neurotransmission, should to be of interest to 
neuroscientists, drug industry and the general public alike.
Neurotransmission regulates a variety of senses and functions such as motivation, memory and muscle contrac-
tion. Neurotransmitters (NTs) play a key role in these functions since the signal transmission takes place through 
the binding of a NT with its specific receptor embedded in the postsynaptic membrane. Understanding the details 
of NT binding is important given that various diseases emerge if the signaling is impaired.
Currently, NTs are depicted in neurobiology textbooks to travel across the synaptic cleft over a distance of 
20–40 nm and to bind to their receptors without interacting with the membrane itself1,2. However, several NT 
receptors (Figure S1, and Table S1 in the Supplementary Information (SI)) contain ligand-binding sites that are 
membrane-buried (Table 1), suggesting possible relevance of the cell membrane in the NT binding.
Until a few decades ago, membranes were considered as passive participants in cellular processes. Recently, 
however, lipids and membranes have been shown to be in a central position in numerous cellular functions 
such as signaling and protein sorting3. The conformation and dynamics as well as the function of various 
membrane-embedded proteins has been shown to be dependent on the lipid composition surrounding mem-
brane proteins4–6. Specific lipids can modulate the stability and function of membrane-embedded proteins by 
diffusing into specific binding sites on their surfaces7,8. For example, cardiolipins have been suggested to facilitate 
proton transfers during cytochrome bc1 complex operation9–13 by binding to locations close to the enzyme’s active 
sites in the mitochondrial membrane9–11.
The effect of lipids and cell membranes is not limited to proteins and peptides but the dynamics of ligands 
and other small molecules is affected, too. For instance, antipsychotic drugs have been shown via numerous 
biophysical methods to interact strongly with lipid membranes12. Membrane permeability is a feature known to 
influence bioavailability of drugs, and major experimental and theoretical effort has been invested to estimate 
ligand permeability across membranes13,14. Furthermore, analgesic drugs such as propofol and even NTs have 
been suggested to produce anesthetic effects by affecting membrane properties such as bilayer thickness15,16. The 
biological effect is, therefore, not necessarily a result of direct ligand-receptor interaction, but the proteins’ func-
tions can be altered via ligand-induced changes in its membrane environment17. To this end, a growing number of 
both experimental and computational studies exploring ligand-membrane interactions are emerging18–20.
A substantial body of work indicates that some ligands first bind to the membrane surface and then diffuse 
laterally into the membrane-buried binding sites of their receptors21. In these cases, the direct 3D diffusion of the 
ligands from the water phase to the receptor’s binding site is transformed into 3D-2D diffusion, which speeds up 
the binding process by several orders of magnitude21. Despite this, the potentially significant effect that the lipid 
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composition exerts on ligand-receptor entry kinetics in the synapse has been largely ignored in previous studies. 
For example with ionotropic glutamate receptors (Table S1), valuable pharmacological data can be acquired by 
concentrating only on their extracellular ligand-binding domains22–27. However, when studying for instance ace-
tylcholine entry into the M3 muscarinic acetylcholine receptor, the lipid composition is a factor that should not be 
overlooked28. Although the positively charged NT is not expected to partition to the cell membrane based on its 
hydrophilic profile, it is yet able to bind effectively into the membrane-buried binding sites of muscarinic recep-
tors as well as into the extracellular binding sites of acetylcholinesterase and nicotinic acetylcholine receptors28.
Several experimental and computational studies have indicated that the lipid composition in membranes 
has a role in NT dynamics. The lipid composition has been shown by molecular dynamics (MD) simulations 
and calorimetry29,30 to affect the NT-membrane dynamics with dopamine. The same result has been shown also 
for glutamate, acetylcholine, γ -aminobutyric acid (GABA) and glycine using MD simulations, calorimetry, and 
dialysis equilibrium experiments31,32. With serotonin, melatonin, and peptidic NT encephalin, attachment to neu-
tral membranes has been also documented by means of neutron scattering33, MD simulations34–36, and nuclear 
Table 1.  The neurotransmitter-membrane association. 1 ( )= .LOG partition coefficient log NT at membraneNT in water[ ][ ]  
2NT was considered bound to the membrane, if it resided within + /− 1 nm from the head group nitrogen atom’s 
average position along the normal to the bilayer surface of either bilayer leaflet. 3The receptors have extracellular 
(EX) and/or membrane-buried (MB) binding sites (Table S1). The binding sites are circled (green). The 
extracellular (red) and intracellular (blue) surfaces are indicated with lines.
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magnetic resonance measurements36. In general, the presence of anionic lipids and the zwitterionic state of NTs 
enhances membrane attachment. Further, determining the role of membrane environment for NT binding in the 
synapses is clearly relevant given that lipids occupy roughly half of the cellular membrane surface area, while the 
other half is taken up by various proteins37.
In this work we performed atomistic MD simulations for three lipid bilayer models with 13 non-peptidic NTs 
and the dopamine precursor L-dopa. The pre-equilibrated lipid membrane models (64 lipids/leaflet; see SI) repro-
duce experimentally determined local bilayer properties such as the order parameter, membrane thickness and 
average area per lipid (e.g, ref. 38,); accordingly, the models are suitable for studying NT-membrane interactions 
that take place at the water-membrane interface.
The first “extracellular” membrane model represents the extracellular leaflet of a synaptic membrane, being 
composed of dioleoylphosphatidylcholine, sphingomyelin, and cholesterol (DOPC/SM/CHOL)37. The second 
“intracellular” model represents a more polar intracellular leaflet and contains dilinoleicphosphatidylcholine, 
dilinoleicphosphatidylethanolamine, and dilinoleicphosphatidylserine (DLPC/DLPE/DLPS)37. Since the exact 
contents of postsynaptic membranes are not known, the lipid compositions of these two models follow the lipid 
contents of typical animal cell membranes. Finally, the third “control” model, containing only DLPC lipids, was 
used as a less polar control membrane. Altogether, 42 NT-membrane systems were simulated for 200–400 ns 
each; furthermore, the membrane binding energetics were determined for four individual NTs using the umbrella 
sampling method.
Based on the MD simulation results the current view of neurotransmission, which does not account for the 
role of lipids1,2, was revised and a holistic theory highlighting the selective effect of cell membrane on synaptic 
neurotransmission was formulated. In short, the simulations provide strong evidence that neurotransmission fol-
lows either the membrane-independent or the membrane-dependent mechanism, and the one chosen by nature 
depends on the position of the receptor’s ligand-binding site.
Results
As expected, the NTs did not permeate the lipid bilayers; instead they displayed varying degrees of reversible 
membrane attachment. Catecholamines such as dopamine and norepinephrine, as well as serotonin, melatonin, 
and adenosine, all attached strongly to the lipid bilayers in the NT-membrane simulations (Fig. 1; Table 1). The 
hydrophobic ring systems were found to be essential for the favorable alignment on the membrane surface. In 
comparison, small NTs containing charged moieties, such as GABA or glutamate (Fig. 2; Table 1), did not attach 
to the membranes. Hydrogen bonding was prominent when NTs attached to the models of the intracellular and 
extracellular leaflets. With the less polar control membrane, hydrophobic/steric attraction was required for close 
contact. The specific NT-membrane interactions are discussed thoroughly in the SI (Figures S3–S11 and Tables 
S2–S4).
The simulations indicate that NTs can be divided into membrane-binding (Fig. 1) and membrane-nonbinding 
groups (Fig. 2). The MD simulations (Table 1), free energy computations (Fig. 3; Table S5), and log P (the octanol/
water partition coefficient) values of the NTs (Fig. 4; Table S3) support this view. Although octanol clearly can-
not depict all of the physical properties and the diversity of an actual lipid bilayer, the log P values corroborate 
the simulation results (Table S3). What is more, this categorization of NTs corresponds to the positioning of the 
ligand-binding sites of their receptors in relation to the postsynaptic membrane (Tables 1 and S1). As a rule of 
thumb, if a NT attached to a membrane, then its ligand-binding site is membrane-buried. In contrast, whenever 
the ligand-binding site is extracellular, then the NT did not attach to the membrane (Table 1).
Based on the divergent behavior observed in the simulations, neurotransmission can be split into two dif-
ferent mechanisms (Fig. 5). The classical membrane-independent mechanism (Fig. 5a), shown in neurobiology 
textbooks, dictates that NTs, whose receptors’ ligand-binding sites are extracellular, travel across the synaptic 
cleft without adhering to the membrane. Thus, these NTs enter their binding site directly from the bulk water. 
The membrane-dependent mechanism (Fig. 5b) proposed in this work dictates that NTs, whose binding sites are 
located in the transmembrane part of the receptor, reversibly attach first to the membrane and then diffuse along 
the membrane surface to the membrane-buried binding site.
Discussion
Although the lipid types residing in synapses are known, the exact lipid compositions of specific synapses or, 
more importantly, their extracellular and intracellular leaflets are yet to be characterized39–42. Keeping this in 
mind, let us consider the perspectives emerging from the simulation data for specific lipid types’ role in the con-
text of NT binding into proteins embedded at the postsynaptic membrane.
The ligand-binding sites of G protein-coupled receptors are typically membrane-buried (Table 1) and their 
representative NTs follow the membrane-dependent mechanism (Fig. 5b). Adenosine, epinephrine, norepi-
nephrine, dopamine, serotonin, and melatonin were found to attach reversibly predominantly to the extracel-
lular and intracellular leaflets in the MD simulations (Table 1), stressing the preference for lipid binding. The 
positively charged histamines attached preferentially to the DLPS-containing intracellular leaflet instead of the 
extracellular membrane surface (Table 1; Figures S8,S9), which suggests that negatively charged lipids could be 
more abundant in synapses housing histamine receptors. For serotonin, there exist several 5-HT receptors with 
membrane-buried binding sites but also 5-HT3 ion channel receptors with extracellular ligand-binding sites 
(Figs 1,2, S6 and S7; Table 1). As serotonin was found to adhere to all three membrane models, assuring sufficient 
amount of NT binding into the extracellular binding sites of 5-HT3 receptors might require for example relatively 
high serotonin levels.
The ligand-gated ion channels such as ionotropic glutamate receptors have extracellular ligand-binding sites. 
Accordingly, their representative NTs follow the membrane-independent mechanism (Fig. 5a). GABA, glycine, 
serine, glutamate, and aspartate prefer the bulk water to the extracellular leaflet (Table 1). Interestingly, in the 
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Figure 1. Density profiles for neurotransmitters with membrane buried binding sites. The density curves 
indicate that adenosine, epinephrine, melatonin, and dopamine attached reversibly to the extracellular leaflet 
surface, and the positively charged acetylcholine and histamine attached to the polar intracellular leaflet. In the 
bottom right corner, extracellular (red) and intracellular (blue) membrane sides and the ligand-binding site 
(green circle) are indicated with lines for the structure of the muscarinic acetylcholine receptor (Table S1).
www.nature.com/scientificreports/
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Figure 2. Density profiles for neurotransmitters with extracellular binding sites. The density curves indicate 
that aspartate, glutamate, serine, glycine, GABA, and acetylcholine do not attach to the extracellular leaflet. For 
serotonin, there exist receptors with membrane-buried binding sites and extracellular binding sites (Table 1), 
but the NT attached to all membranes. Also shown (on the right, bottom) are the extracellular binding sites of 
the GluA2 glutamate receptor and the 5HT-3 serotonin receptor (Table S1).
www.nature.com/scientificreports/
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cases of serine and acetylcholine, the polar intracellular leaflet was preferred to the bulk water (Figures S8,S9). 
The fact that acetylcholine attaches to the intracellular surface, and not to the extracellular leaflet, provides an 
explanation for how muscarinic acetylcholine receptors can have membrane-buried ligand-binding sites while 
nicotinic acetylcholine receptors have extracellular binding sites (Table 1). Namely, those synapses or membrane 
regions populated by muscarinic receptors could yet again have more negatively charged lipids attracting the 
positively charged acetylcholine molecules than those populated by nicotinic receptors. Altogether, the results 
suggest that specific lipids, and charged types in particular, may modulate the association of NTs to their host 
membranes, and hence the binding to their receptors.
The above described results suggest that specific lipid types and the lipid composition in general could have 
an important role in synaptic neurotransmission. While the concentrations of negatively charged glycolipids are 
usually small in typical animal cells, their levels are known to be higher in neurons39,40. Thus, these anionic lipids 
at the extracellular leaflet of the postsynaptic membrane could facilitate the membrane attachment of positively 
charged histamine or acetylcholine molecules. While the effect of glycolipids was not addressed in this work, the 
simulations indicate that charged lipids (here DLPS) do affect the partitioning of NTs (Table 1).
Tightly regulated lipid composition differences between synapses could ensure that acetylcholine can bind 
into both membrane-buried and extracellular ligand-binding sites (Table 1; Figures S8,S9). In fact, the lipid com-
position may also be an important factor in neurological diseases and/or their diagnostics. Post mortem studies 
Figure 3. Profiles of free energy obtained from umbrella sampling calculations. The profiles indicate that 
norepinephrine, dopamine and serotonin adhere to the membrane surfaces, while glutamate does not. Both 
the 2D structures of NTs and the 3D receptor structures are shown in the figures. For comparison, the NT-
membrane reversible attachment is observed in the end of the extracellular leaflet simulations, too.
Figure 4. Lipophilicity classifies neurotransmitters into membrane-nonbinding and membrane-binding 
categories. 
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have indicated changes in the lipid composition with schizophrenia, Parkinson’s disease, and Alzheimer’s disease 
patients43–46. The membrane reversible attachment of a NT could be either enhanced or weakened, if the mem-
brane became less or more charged due to changes in lipid composition. Although the absolute NT levels would 
not necessarily be affected by these changes, an imbalance in NT-membrane interactions could contribute to 
disease states such as depression.
Synaptic receptors are not the only membrane-embedded proteins that interact with NTs at the postsynaptic 
membrane. The timely removal of NTs from the synaptic cleft is vital and, for example, if glutamate transport is 
obstructed, neurotoxic effects follow47. In this regard, the NT-membrane simulations shed new light also on NT 
transport across the postsynaptic membrane following neurotransmission.
It may seem contradictory, but all NTs eventually bind into the membrane-buried ligand-binding sites of 
their transporters (Figure S12a,b). The Na+ gradient across the membrane powers the Na+/NT co-transport. In 
addition, the positive ion(s) at the ligand-binding sites form ionic bonds with NTs that have carboxylate groups 
(shown for leucine in Figure S12b)48. With monoamines such as serotonin, which partition readily to the mem-
brane (Table 1), an aspartate side chain acts as an intrinsic ligand which neutralizes the positive charge48. In the 
glutamate transporter the Na+ binding takes place prior to the NT entry49. Thus, the positively charged ions inside 
the membrane-buried ligand-binding sites of NT transporters could act as sinks that attract negatively charged 
NTs such as glutamate and aspartate.
This sink hypothesis is not valid for neutral ligands, but all non-peptidic NTs were somewhat attracted to the 
polar intracellular membrane in the simulations, serine even preferred it over the bulk water (Figures S10,S11; 
Table 1). Conceivably, the NT transporters could be surrounded by high concentrations of anionic lipids such as 
glycolipids. Indeed, lipid composition differences have been suggested to affect, for example, glutamate uptake50. 
Notably, the removal of acetylcholine from the synaptic cleft is different as the positively charged NT binds into 
the extracellular ligand-binding site of acetylcholinesterase (Figure S12c) and the reaction products are trans-
ported separately into the cytoplasm.
In a broader context, the simulations suggest a strong interplay between lipids, membrane proteins, and NTs, 
and coevolution at the postsynaptic membrane. The NTs not only have to pass the on/off test of the membrane 
and match the properties of their receptors’ active sites in the synapse, but the membrane effect likely applies to 
the intracellular NT dynamics as well. However, it is important to recognize that drugs or natural compounds 
such as toxins do not necessarily follow the same logic as the NTs regarding the membrane partitioning. For 
Figure 5. Neurotransmission models. (a) Classical membrane-independent mechanism: (1) neurotransmitter 
release; (2) random diffusion; and (3) binding into the extracellular ligand-binding sites of the receptors.  
(b) Membrane-dependent mechanism: (1) neurotransmitter release; (2) aggregation to the membrane; and  
(3) lateral diffusion followed by binding into the membrane-buried ligand-binding sites.
www.nature.com/scientificreports/
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example, potent acetylcholinesterase inhibitors can be very lipophilic despite the fact that the enzyme’s active site 
is extracellular (Table S6). This discrepancy highlights the extraordinary importance of fast and coordinated NT 
kinetics for neurotransmission. Despite this, avoiding ligand-membrane mismatches during drug development 
should reduce off-target effects and increase efficacy with a multitude of target proteins.
In conclusion, the atomistic MD simulations suggest that non-peptidic NTs are divided into 
membrane-binding and membrane-nonbinding categories that in turn correspond to the positioning of their 
receptor’s ligand-binding sites in relation to the postsynaptic membrane (Table 1). Hence, neurotransmission 
follows either the membrane-dependent or the membrane-independent mechanism (Fig. 5). Despite the apparent 
simplicity of this finding, it represents a fundamentally different outlook on neurotransmission with far-reaching 
ramifications. The selective effect of the membrane ensures a more coordinated response to NT release than 
random diffusion could accomplish alone. By controlling the lipid composition, and paying attention to the extra-
cellular leaflet in particular in different synapses in the nervous system, NTs such as acetylcholine could bind 
efficiently into membrane proteins with both extracellular and membrane-buried ligand-binding sites. Moreover, 
anionic lipids promote the membrane partitioning of all studied non-peptidic NTs in the simulations (Table 1) 
and, thus, the presence of negatively charged lipids in the synapse could be a requirement for efficient removal of 
NTs from the synaptic cleft.
Methods
The atomistic molecular dynamics (MD) simulations were performed with GROMACS 4.551 using the OPLS-AA 
force field38,52,53. The MD simulation protocol was presented in a previous study38. Free energy curves were cal-
culated using umbrella sampling54 together with the Weighted Histogram Analysis Method55. VMD1.9.1 was 
used to draw the 3D structures of receptors56. Altogether, 42 NT-membrane systems were simulated, each for 
200–300 ns (total simulation time being ~12 μ s). The computational methods are explained in detail in SI.
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